ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

TALS Talaris Therapeutics Inc

2.72
0.00 (0.00%)
Última actualización: 19:00:00
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Talaris Therapeutics Inc TALS NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 2.72 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.72
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
19/4/202415:05EDGAR2Form ARS - Annual Report to Security Holders
19/4/202415:04EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
19/4/202415:02EDGAR2Form DEF 14A - Other definitive proxy statements
19/3/202416:10EDGAR2Form S-8 - Securities to be offered to employees in employee..
19/3/202416:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
19/3/202406:09EDGAR2Form 8-K - Current report
20/11/202317:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202317:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/11/202315:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
30/10/202315:15EDGAR2Form SC 13D/A - General statement of acquisition of..
27/10/202316:17EDGAR2Form 8-K - Current report
27/10/202315:02EDGAR2Form SC 13G - Statement of acquisition of beneficial..
26/10/202316:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/10/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/10/202315:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/10/202320:23EDGAR2Form S-8 - Securities to be offered to employees in employee..
17/10/202316:47GLOBETalaris Therapeutics Announces Stockholder Approval of..
10/10/202315:32EDGAR2Form 425 - Prospectuses and communications, business..
10/10/202315:30EDGAR2Form 8-K/A - Current report: [Amend]
06/10/202319:01DJNStocks to Watch: Shift Technologies, Talaris Therapeutics,..
06/10/202316:30EDGAR2Form 8-K - Current report
06/10/202316:27EDGAR2Form 425 - Prospectuses and communications, business..
06/10/202316:26EDGAR2Form 8-K - Current report
06/10/202316:09GLOBETalaris Therapeutics Declares Special Dividend In Connection..
04/10/202307:30GLOBENew York Blood Center Enterprises Acquires Commercial-Scale..
26/9/202307:24EDGAR2Form 425 - Prospectuses and communications, business..
26/9/202307:21EDGAR2Form 8-K - Current report
15/9/202305:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/9/202315:28EDGAR2Form S-4/A - Registration of securities, business..
13/9/202308:14EDGAR2Form 425 - Prospectuses and communications, business..
13/9/202308:13EDGAR2Form 8-K - Current report
11/9/202315:47EDGAR2Form S-4/A - Registration of securities, business..
28/8/202306:38EDGAR2Form 425 - Prospectuses and communications, business..
25/8/202315:34EDGAR2Form S-4/A - Registration of securities, business..
14/8/202306:53EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
22/6/202306:30GLOBETalaris Therapeutics and Tourmaline Bio Announce Merger..
26/5/202306:00GLOBETalaris Therapeutics Announces Leadership Transition

Su Consulta Reciente

Delayed Upgrade Clock